Panion & Bf Biotech Inc. (TPE:1760)
64.10
+0.10 (0.16%)
At close: Mar 24, 2026
Panion & Bf Biotech Revenue
In the year 2025, Panion & Bf Biotech had annual revenue of 2.06B TWD with 1.66% growth. Panion & Bf Biotech had revenue of 546.14M in the quarter ending December 31, 2025, with 4.52% growth.
Revenue
2.06B
Revenue Growth
+1.66%
P/S Ratio
2.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.06B | 33.75M | 1.66% |
| Dec 31, 2024 | 2.03B | 147.77M | 7.85% |
| Dec 31, 2023 | 1.88B | -516.77M | -21.54% |
| Dec 31, 2022 | 2.40B | 497.44M | 26.16% |
| Dec 31, 2021 | 1.90B | 332.57M | 21.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.37B |
| Medigen Biotechnology | 1.58B |
| Savior Lifetec | 1.20B |
| Pharmosa Biopharm | 67.27M |
| OBI Pharma | 58.58M |
| UnicoCell Biomed | 30.10M |
| AnnJi Pharmaceutical | 23.85M |
| Locus Cell | 5.18M |